10/25/2017

Cambridge Biomedical's Fall 2017 Newsletter

Cambridge Biomedical's Fall 2017 Newsletter

Cambridge Biomedical's Fall 2017 Newsletter
Welcome to our third Cambridge Biomedical newsletter of 2017. Read below for upcoming activities, areas where we have contributed this year, and insight into conducting science in space.

CAR T-Cell Therapy: Engineering the patients' immune cells to target and kill their cancer

The recent approvals, by the FDA, of the first chimeric antigen receptor (CAR) T-cell therapies are significant treatment breakthroughs, a true milestone in cancer therapy.
 
Cambridge Biomedical is privileged to contribute in this exciting and promising new immunotherapy, as we work in collaboration with researchers in the field, utilizing our strengths with complex esoteric testing.  
 
To learn more about our outlook, expertise and capabilities in this area click here.
 

Second Biannual Scientific Lunch December 12th in Cambridge, MA

"Synthetic Biotic™ Medicines: A New Class of Treatments."
Dr. Yves Millet, Synlogic
 

Tuesday, December 12, 2017, 11:30AM to 1PM.  
Catalyst Restaurant 300 Technology Square, Cambridge, MA 02139.   
RSVP Required.

Please save the date.  Cambridge Biomedical will be hosting its second Scientific Luncheon December 12th in Kendall Square.  An announcement will be made shortly with more details. 

The fields of synthetic biology and microbiome research have expanded greatly over the last decade enabling the development of new therapeutic strategies using engineered microbes that operate from within the gut. Synlogic is pioneering the development of a novel class of engineered, living drugs, called Synthetic Biotic™ Medicines, that can be designed to correct missing or dysfunctional metabolic activities or deliver effectors in the GI tract, with the potential to treat a wide range of diseases. The opportunities and challenges of this new therapeutic platform and the results obtained with two lead programs for the treatment of Urea Cycle Disorder and Phenylketonuria will be presented.
 
Find out more

Can you Pipette without Gravity ?

Consider running scientific experiment in what could arguably be considered the most inconvenient location to conduct assays - the International Space Station(ISS). The Whitehead Institute hosted a visit by one of their alumna, Dr. Kate Rubins.
 
To read the complete article click here An Evening with NASA Astronaut Kathleen Rubins 

Workshop Plans for 2018

Besides the scientific lunches we are considering hosting a 1/2 day Workshop to go over aspects of up and coming therapies, assays, and insight into areas that are impacting drug development researchers.  Please be on the look out at the beginning of 2018 for a survey to collect your feedback to better structure the workshop to meet your needs and provide true value.

David Osband | Cambridge Biomedical | 617-456-0760 |

  
Latest News   

 Subscribe to our blog

Events

Cambridge Biomedical's Biannual Scientific Meeting - Microbiome Luncheon

Tuesday, December 12, 2017  11:30AM to 1:00PM

Catalyst Restaurant                  300 Technology Square,   Cambridge MA 02139

For existing clients & test results please contact 
Customer Service:617.456.0800
All rights reserved. Cambridge Biomedical, the Cambridge Biomedical logo, Science and Service, and Custom
Solutions for Life Sciences Companies are registered or unregistered trademarks of Cambridge Biomedical Inc.
|     Privacy Statement     | Terms of Use